Elevance Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Elevance Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Elevance Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $271M, a 44.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $271M +$84M +44.9% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $187M -$25M -11.8% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $212M +$128M +152% Dec 31, 2021 10-Q 2023-10-18
Q4 2020 $84M +$39M +86.7% Dec 31, 2020 10-K 2022-02-16
Q4 2019 $45M Dec 31, 2019 10-K 2021-02-18
Q4 2015 $0 -$2.6M -100% Dec 31, 2015 10-K 2016-02-19
Q4 2014 $2.6M -$21.5M -89.2% Dec 31, 2014 10-K 2016-02-19
Q4 2013 $24.1M +$6M +33.1% Dec 31, 2013 10-K 2015-02-24
Q4 2012 $18.1M +$7.1M +64.5% Dec 31, 2012 10-K 2014-02-20
Q4 2011 $11M $0 0% Dec 31, 2011 10-K 2013-02-22
Q4 2010 $11M Dec 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.